Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Thomas Jefferson University
Thomas Jefferson University
Revolution Medicines, Inc.
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Revolution Medicines, Inc.
Erasca, Inc.
Blueprint Medicines Corporation
Revolution Medicines, Inc.
Syndax Pharmaceuticals
Syndax Pharmaceuticals
The Methodist Hospital Research Institute
H. Lee Moffitt Cancer Center and Research Institute
VA Office of Research and Development